Exploration of Targeted Anti-tumor Therapy

Open Access Review

Interface between obesity with dysfunctional metabolism and inflammation, and the triple-negative breast cancer in African American women

Katarzyna Rygiel

Published: December 31, 2021 Explor Target Antitumor Ther. 2021;2:602–616

DOI: https://doi.org/10.37349/etat.2021.00066

This article belongs to the special issue Endocrine Resistant Breast Cancer

Full Text PDF

2645 58 1

Open Access Original Article

The bromodomain and extra-terminal domain degrader MZ1 exhibits preclinical anti-tumoral activity in diffuse large B-cell lymphoma of the activated B cell-like type

Chiara Tarantelli ... Francesco Bertoni

Published: December 31, 2021 Explor Target Antitumor Ther. 2021;2:586–601

DOI: https://doi.org/10.37349/etat.2021.00065

This article belongs to the special issue Proteolysis Targeting Chimera (PROTAC)

Full Text PDF

4408 109 5

Open Access Original Article

Physical characteristics comparison between maytansinoid-based and auristatin-based antibody-drug conjugates

Tomohiro Fujii ... Yutaka Matsuda

Published: December 31, 2021 Explor Target Antitumor Ther. 2021;2:576–585

DOI: https://doi.org/10.37349/etat.2021.00064

This article belongs to the special issue Antibody-Drug Conjugates

Full Text PDF

4888 199 12

Open Access Original Article

Alterations in the Ca²⁺ toolkit in oesophageal adenocarcinoma

Alana L. Cutliffe ... John J. Mackrill

Published: December 31, 2021 Explor Target Antitumor Ther. 2021;2:543–575

DOI: https://doi.org/10.37349/etat.2021.00063

This article belongs to the special issue Calcium Signaling Apparatus in Cancers

Full Text PDF

3528 59 2

Open Access Review

Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies

Stefano Cavalieri ... Laura D. Locati

Published: December 31, 2021 Explor Target Antitumor Ther. 2021;2:522–542

DOI: https://doi.org/10.37349/etat.2021.00062

This article belongs to the special issue Immunotherapy in Cancer Patients

Full Text PDF

3831 103 7

Open Access Review

The clinical advances of proteolysis targeting chimeras in oncology

Hao Xie ... Jason B. Fleming

Published: December 31, 2021 Explor Target Antitumor Ther. 2021;2:511–521

DOI: https://doi.org/10.37349/etat.2021.00061

This article belongs to the special issue Proteolysis Targeting Chimera (PROTAC)

Full Text PDF

6615 238 25

Open Access Review

Proteolysis-targeting chimeras and their implications in breast cancer

Angeles C. Tecalco-Cruz ... Alberto Rojas-Ochoa

Published: December 31, 2021 Explor Target Antitumor Ther. 2021;2:496–510

DOI: https://doi.org/10.37349/etat.2021.00060

This article belongs to the special issue Proteolysis Targeting Chimera (PROTAC)

Full Text PDF

4042 103 6